Skip to main content
Premium Trial:

Request an Annual Quote

Celera Closes $33M Atria Acquisition

NEW YORK (GenomeWeb News) — Celera today said it has closed its $33 million acquisition of Atria Genetics, a maker of human leukocyte antigen-testing products used in organ donor matching.
 
Celera said it plans to integrate all of Atria’s 13 employees into its company.
 
Celera also said it expects the acquisition will be accretive to its earnings by the second half of 2008.
 
The company disclosed its plans to buy the South San Francisco, Calif.-based company last month.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.